The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 |
doi: 10.3389/fimmu.2025.1480771
Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancers progression and immune infiltration
Provisionally accepted
Xinyue Shi 1
Jingyu Zang 1* Qi Gu 1* Mengmeng Zhang 1*
Handi Sun 1
Li Jun Y ang 1 Jiahui Cheng 1* Ruonan Wang 1* Han Mao 1* Aitong Xu 1* Xin Wang 1*
Yu Xiao 1
Jialing Cai 2 Fang Han 1*
Depeng Yang 1* Yu Li 1*
HUAN NIE 1*- 1 Harbin Institute of Technology, Harbin, China
- 2 Harbin Medical University, Harbin, Heilongjiang, China
Background: Digestive system cancers are among the most common malignancies, exhibiting consistently high incidence and mortality rates, yet effective detection and treatment targets remain limited. Integrin αv (ITGAV, CD51) is a significant member of the integrin family, widely recognized for its role in mediating interactions between cells and the extracellular matrix, as well as intracellular signaling. In recent years, ITGAV has been found to have significantly elevated expression in multiple tumors, such as prostate cancer, breast cancer, and osteosarcoma, and was considered to be a key component in various stages of tumor progression. However, no systematic digestive system cancer analysis has been conducted to explore its function in prognosis, diagnosis, and immunology.Methods: Transcriptome sequencing and clinical data of samples were obtained from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression Project (GTEx), Human Protein Atlas (HPA), cBioPortal, TIMER and TISIDB databases. Bioinformatics methods were employed to investigate the potential oncogenicity of ITGAV, focusing specifically on the analysis of its prognosis, diagnostic value, and immune infiltration level of ITGAV in digestive system cancers. In addition, GO, KEGG, and PPI network analysis revealed the biological functions and related signaling pathways related to ITGAV. Finally, the role of ITGAV in regulating cancer progression was experimentally verified using hepatocellular carcinoma and pancreatic cancer as examples.Results: We found that ITGAV was highly expressed in multiple digestive system cancers. In addition, high expression of ITGAV was closely associated with poor prognosis and showed potential for early diagnosis. Enrichment of pathways related to extracellular matrix organizing processes and tumor migratory movements was identified. In vitro, results showed that the knockdown of ITGAV significantly inhibited the migratory movement ability of hepatocellular carcinoma and pancreatic cancer cells, while its overexpression significantly promoted the migration of the above cells. Finally, immunoassays showed a significant correlation between ITGAV expression and the infiltration level of various immune cells, further clarifying the critical role of ITGAV in the tumor immune microenvironment.Conclusion: Our results elucidated the importance of ITGAV in the prognostic assessment, early diagnosis, and targeted immunotherapy of digestive system cancers, and revealed its multifaceted role in regulating cancer progression.
Keywords: ITGAV, diagnosis, Migration, immunology, Digestive system cancers
Received: 14 Aug 2024; Accepted: 24 Jan 2025.
Copyright: © 2025 Shi, Zang, Gu, Zhang, Sun, Y ang, Cheng, Wang, Mao, Xu, Wang, Xiao, Cai, Han, Yang, Li and NIE. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jingyu Zang, Harbin Institute of Technology, Harbin, China
Qi Gu, Harbin Institute of Technology, Harbin, China
Mengmeng Zhang, Harbin Institute of Technology, Harbin, China
Jiahui Cheng, Harbin Institute of Technology, Harbin, China
Ruonan Wang, Harbin Institute of Technology, Harbin, China
Han Mao, Harbin Institute of Technology, Harbin, China
Aitong Xu, Harbin Institute of Technology, Harbin, China
Xin Wang, Harbin Institute of Technology, Harbin, China
Fang Han, Harbin Institute of Technology, Harbin, China
Depeng Yang, Harbin Institute of Technology, Harbin, China
Yu Li, Harbin Institute of Technology, Harbin, China
HUAN NIE, Harbin Institute of Technology, Harbin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.